https://www.fda.gov/safety/medical-product-safety-information/copiktra-duvelisib-drug-safety-communication-fda-warns-about-possible-increased-risk-death-and
Copiktra (duvelisib): Drug Safety Communication - FDA Warns about Possible Increased Risk of Death...
FDA is warning that results from a clinical trial show a possible increased risk of death with Copiktra (duvelisib) compared to another medicine to treat a...
https://www.techtarget.com/pharmalifesciences/news/366606741/FDA-Releases-Drug-Safety-Communication-regarding-Cancer-Drug-Copiktra
FDA Releases Drug Safety Communication regarding Cancer Drug, Copiktra | TechTarget
The FDA recently released a warning, via drug safety communication, on the potential risks associated with the cancer drug Copiktra.
drug safetyfdareleasescommunicationregarding